Articles with "similarity pharmacokinetic" as a keyword



Photo by nci from unsplash

Assessment of quality and clinical similarity (pharmacokinetic and safety) of HD204, a biosimilar of bevacizumab.

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2020.38.15_suppl.e21556

Abstract: e21556Background: Prestige Biopharma Pte Ltd is developing HD204, a biosimilar candidate of Bevacizumab (Avastin). Bevacizumab has been approved in the treatment of a variety of metastatic tumours.... read more here.

Keywords: assessment quality; bevacizumab; hd204 biosimilar; quality clinical ... See more keywords